» Articles » PMID: 8496675

Clone-specific T Cell Receptor Antagonists of Major Histocompatibility Complex Class I-restricted Cytotoxic T Cells

Overview
Journal J Exp Med
Date 1993 Jun 1
PMID 8496675
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

A previous report showed that the proliferative response of helper T cells to class II major histocompatibility complex (MHC)-restricted antigens can be inhibited by analogues of the antigen, which act as T cell receptor (TCR) antagonists. Here we define and analyze peptide variants that antagonize various functions of class I MHC-restricted cytotoxic T lymphocyte (CTL) clones. Of 64 variants at individual TCR contact sites of the Kb-restricted octamer peptide ovalbumin257-264 (OVAp), a very high proportion (40%) antagonized lysis by three OVAp-specific CTL clones. This effect was highly clone specific, since many antagonists for one T cell clone have differential effects on another. We show that this inhibition of CTL function is not a result of T cell-T cell interaction, precluding veto-like phenomena as a mechanism for antagonism. Moreover, we present evidence for direct interaction between the TCR and antagonist-MHC complexes. In further analysis of the T cell response, we found that serine esterase release and cytokine production are susceptible to TCR antagonism similarly to lysis. Ca2+ flux, an early event in signaling, is also inhibited by antagonists but may be more resistant to the antagonist effect than downstream responses.

Citing Articles

Single-cell NAD(H) levels predict clonal lymphocyte expansion dynamics.

Turner L, Van Le T, Cross E, Queriault C, Knight M, Trihemasava K Sci Immunol. 2024; 9(93):eadj7238.

PMID: 38489349 PMC: 11064129. DOI: 10.1126/sciimmunol.adj7238.


Regulating the discriminatory response to antigen by T-cell receptor.

Gangopadhyay K, Roy S, Sen Gupta S, Chandradasan A, Chowdhury S, Das R Biosci Rep. 2022; 42(3).

PMID: 35260878 PMC: 8965820. DOI: 10.1042/BSR20212012.


HLA-DRB1 genes and the expression dynamics of HLA CIITA determine the susceptibility to T2DM.

Chinniah R, Sevak V, Pandi S, Ravi P, Vijayan M, Kannan A Immunogenetics. 2021; 73(4):291-305.

PMID: 33754173 DOI: 10.1007/s00251-021-01212-x.


Vaccination with Altered Peptide Ligands of a Circumsporozoite Protein CD8 T-Cell Epitope: A Model to Generate T Cells Resistant to Immune Interference by Polymorphic Epitopes.

Minigo G, Flanagan K, Slattery R, Plebanski M Front Immunol. 2017; 8:115.

PMID: 28261200 PMC: 5306364. DOI: 10.3389/fimmu.2017.00115.


On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy).

Candia M, Kratzer B, Pickl W Int Arch Allergy Immunol. 2016; 170(4):211-233.

PMID: 27642756 PMC: 7058415. DOI: 10.1159/000448756.


References
1.
Dexter T, Garland J, Scott D, Scolnick E, Metcalf D . Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med. 1980; 152(4):1036-47. PMC: 2185980. DOI: 10.1084/jem.152.4.1036. View

2.
Racioppi L, Ronchese F, Matis L, Germain R . Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J Exp Med. 1993; 177(4):1047-60. PMC: 2190984. DOI: 10.1084/jem.177.4.1047. View

3.
Pasternack M, Eisen H . A novel serine esterase expressed by cytotoxic T lymphocytes. Nature. 1985; 314(6013):743-5. DOI: 10.1038/314743a0. View

4.
Rabinovitch P, June C, Grossmann A, Ledbetter J . Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry. J Immunol. 1986; 137(3):952-61. View

5.
Fink P, Shimonkevitz R, Bevan M . Veto cells. Annu Rev Immunol. 1988; 6:115-37. DOI: 10.1146/annurev.iy.06.040188.000555. View